These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9672061)

  • 1. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction.
    Kooner JS; Baliga RR; Wilding J; Crook D; Packard CJ; Banks LM; Peart S; Aitman TJ; Scott J
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1021-6. PubMed ID: 9672061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.
    Aitman TJ; Godsland IF; Farren B; Crook D; Wong HJ; Scott J
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):748-54. PubMed ID: 9108790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.
    Schauer IE; Snell-Bergeon JK; Bergman BC; Maahs DM; Kretowski A; Eckel RH; Rewers M
    Diabetes; 2011 Jan; 60(1):306-14. PubMed ID: 20978091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect?
    Dhawan J; Bray CL; Warburton R; Ghambhir DS; Morris J
    Br Heart J; 1994 Nov; 72(5):413-21. PubMed ID: 7818957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between central adiposity and lipaemia in UK Sikh men.
    Lovegrove JA; Brady LM; Lesauvage SV; Lovegrove SS; Minihane AM; Williams CM
    Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1373-82. PubMed ID: 14574349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance.
    Toft I; Bønaa KH; Lindal S; Jenssen T
    Metabolism; 1998 Jul; 47(7):848-54. PubMed ID: 9667234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.
    Laakso M; Sarlund H; Mykkänen L
    Arteriosclerosis; 1990; 10(2):223-31. PubMed ID: 2180396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
    Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.
    Frias JP; Macaraeg GB; Ofrecio J; Yu JG; Olefsky JM; Kruszynska YT
    Diabetes; 2001 Jun; 50(6):1344-50. PubMed ID: 11375335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects.
    Balletshofer BM; Rittig K; Volk A; Maerker E; Jacob S; Rett K; Häring H
    Horm Metab Res; 2001 Jul; 33(7):428-31. PubMed ID: 11507681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
    Ter Horst KW; Gilijamse PW; Ackermans MT; Soeters MR; Nieuwdorp M; Romijn JA; Serlie MJ
    Metabolism; 2016 May; 65(5):757-763. PubMed ID: 27085782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose tolerance, serum insulin and lipid abnormalities in patients with coronary heart disease.
    Inoue S; Ota M; Iizuka T; Murao S
    Jpn Heart J; 1975 Nov; 16(6):670-82. PubMed ID: 1185889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.